What is Generate Biomedicines, Inc. 's market cap?

Generate Biomedicines, Inc. (GENB) has a market capitalization of $1.9B and trades on XNAS.

Where is Generate Biomedicines, Inc. headquartered?

Generate Biomedicines, Inc. is headquartered in United States of America. It has been publicly traded since 2026.

Generate Biomedicines, Inc.

GENB

Generate Biomedicines, Inc. is a asset management company in the financial services sector trading on XNAS, led by CEO Michael T. Nally, with a market cap of $1.9B.

Market cap

$1.86B+30.0%

Table of contents

Earnings

Next report

Aug 6, 2026 (in a month)

Revenue estimate$5.3M

EPS estimate-$0.48

Financials

Q1 2026

Income statement

See full

Revenue$7.2M-18.1%

Operating income-$64.1M-33.1%

Net income-$61.4M-47.4%

EPS (diluted)-$1.07+34.0%

Balance sheet

See full

Cash & equivalents$160.6M-27.2%

Total debt$65.6M—

Total equity$514.8M+209%

Total assets$625.7M—

Cash flow

See full

Operating cash flow-$80.4M-51.2%

CapEx$3.8M+403%

Free cash flow-$84.2M-56.1%

Valuation & ratios

Valuation

See full

Market cap$1.86B—

Enterprise value$1.76B—

Returns & leverage

See full

Debt / equity0.1×—

Current ratio9.2×—

Profile

CountryUnited States of America

Listed2026

CEOMichael T. Nally

SectorFinancial Services

IndustryAsset Management

Websitegeneratebiomedicines.com

FilingsSEC EDGAR

Questions, answered.

What is Generate Biomedicines, Inc. 's market cap?: Generate Biomedicines, Inc. (GENB) has a market capitalization of $1.9B and trades on XNAS.
Where is Generate Biomedicines, Inc. headquartered?: Generate Biomedicines, Inc. is headquartered in United States of America. It has been publicly traded since 2026.